Viewing Study NCT04708418


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2025-12-26 @ 3:50 AM
Study NCT ID: NCT04708418
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2021-01-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module